Observational of PNH Type Cells in Korean Patients With Bone Marrow Failure Syndrome and Having Hemolytic PNH
NCT03460301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 233
Last updated 2025-01-27
Summary
Patients who are positive of PNH-type cells are followed up for the percentage of PNH-type cells regularly for examining how it change.
Conditions
- PNH
Sponsors & Collaborators
-
Handok Inc.
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-24
- Primary Completion
- 2020-08-12
- Completion
- 2020-08-12
More Related Trials
-
Functional and Mechanistic Characterization of Limb Ulcers in Patients With Sickle Cell Disease
NCT04983654 ·Status: COMPLETED ·Phase: NA
-
Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events
NCT02539771 ·Status: COMPLETED ·Phase: NA
-
Anemia in the Elderly
NCT00640172 ·Status: COMPLETED
-
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
NCT01760096 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Global Coagulation Tests in Patients With Paroxysmal Nocturnal Haemoglobinuria
NCT01020188 ·Status: COMPLETED
-
A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06050226 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH）
NCT06561841 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06745622 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT06134414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT00039923 ·Status: COMPLETED
-
Genomic Screening for Hereditary Erythrocytosis and Related Diseases
NCT03263364 ·Status: UNKNOWN
-
Kidney Function in Sickle Cell Anemia
NCT03277547 ·Status: ACTIVE_NOT_RECRUITING
-
Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor
NCT03656172 ·Status: COMPLETED
-
Clinical Study Evaluating the Efficacy of Iron Proteinsuccinylate Oral Solution（FERPLEX） in Women With Gynecologic Iron Deficiency Anemia
NCT05192291 ·Status: UNKNOWN
-
National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia
NCT07019038 ·Status: RECRUITING
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
NCT05214105 ·Status: RECRUITING
-
Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
NCT04128943 ·Status: COMPLETED
-
Pharmacokinetics of Oral Hydroxyurea Solution
NCT03763656 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06933914 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)
NCT03371173 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Iron Oligosaccharide in CHF Patients
NCT00537186 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"
NCT06735625 ·Status: RECRUITING ·Phase: NA
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
NCT01642979 ·Status: UNKNOWN ·Phase: PHASE2